Alectinib hydrochloride
Alectinib hydrochloride is a potent and selective oral ALK inhibitor with an IC50 of 1.9 nM. It is widely used in preclinical research for studying non-small cell lung cancer (NSCLC), demonstrating efficacy in both cellular assays and in vivo models of ALK-driven tumors.
Product Specifications
CAS Number
1256589-74-8
Product Name Alternative
CD246, Cluster of differentiation 246, CH 5424802, CH5424802, CH-5424802, CH5424802 (Hydrochloride), Anaplastic lymphoma kinase, Anaplastic lymphoma kinase (ALK), AF802, AF-802, AF-802 (Hydrochloride), AF 802, Alectinib, Alectinib hydrochloride, Alectinib Hydrochloride, ALK, ALK tyrosine kinase receptor, inhibit, Inhibitor, RO5424802, RO-5424802, RO5424802 (Hydrochloride), RO 5424802
Field of Research
Cardiovascular Research, Pharmacology & Drug Discovery, Signal Transduction
Purity
99.61% (May vary between batches)
Solubility
DMSO:6.25 mg/mL (12.04 mM)
Smiles
Cl.CCc1cc2C (=O) c3c ([nH]c4cc (ccc34) C#N) C (C) (C) c2cc1N1CCC (CC1) N1CCOCC1
Molecular Formula
C30H35ClN4O2
Molecular Weight
519.08
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
